Real-world Characterization and Use of Insertable Cardiac Monitor Remote Programming
- PMID: 36570481
- PMCID: PMC9721296
- DOI: 10.19102/icrm.2022.13112
Real-world Characterization and Use of Insertable Cardiac Monitor Remote Programming
Abstract
Remote device programming may enable workflow efficiencies and reduce resource strains on clinics as well as patients. Although the remote patient management ecosystem has evolved, several challenges remain, and the role of remote device programming for an insertable cardiac monitor (ICM) has yet to be described in a real-world setting. The purpose of this study was to characterize the initial real-world use of remote programming of an ICM. The cohort included 8,238 patients with the LUX-Dx™ ICM (Boston Scientific, Marlborough, MA, USA) during the first year of commercial use, which is also the first year that remote programming was available for an ICM. A descriptive review of reprogramming events revealed that 24% of devices were reprogrammed and that 82% of all reprogramming events occurred remotely. Over 74% of first reprogramming events occurred within the first 30 days following device insertion, and nearly 80% of devices only had 1 reprogramming event. These early data support the hypothesis that remote programming of an ICM is a clinically useful tool that may improve the clinical experience of device programming optimization, especially within the first month following device insertion.
Keywords: Cryptogenic stroke; insertable cardiac monitor; remote monitoring; remote programming; syncope.
Copyright: © 2022 Innovations in Cardiac Rhythm Management.
Conflict of interest statement
Drs. Mahajan, Frost, and Herrmann are employees of Boston Scientific. Ms. McGee-Taylor collects consulting fees from Boston Scientific and Abbott. No funding information was provided for this study. Study analyses were supported by Boston Scientific.
Figures
References
-
- Varma N, Marrouche NF, Aguinaga L, et al. HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic. Heart Rhythm. 2020;17(9):e255–e268. [CrossRef] [PubMed] - DOI - PMC - PubMed
-
- Nouri SS, Khoong EC, Lyles CR, Karliner LS. Addressing equity in telemedicine for chronic disease management during the Covid-19 pandemic. NEJM Catal. 2020:1–13.
-
- Abraham WT, Fiuzat M, Psotka MA, O’Connor CM. Heart failure collaboratory statement on remote monitoring and social distancing in the landscape of COVID-19. JACC Heart Fail. 2020;8(8):692–694. [CrossRef] [PubMed] - DOI - PMC - PubMed
-
- Okabe T, Afzal MR, Hummel JD, et al. First clinical use of real-time remote programming in cardiac implantable electronic devices. J Cardiovasc Electrophysiol. 2020;31(10):2759–2761. [CrossRef] [PubMed] - DOI - PubMed
-
- Alexander B, Baranchuk A. Remote device reprogramming: has its time come? Circ Arrhythm Electrophysiol. 2020;13(10):e008949. [CrossRef] [PubMed] - DOI - PubMed
LinkOut - more resources
Full Text Sources